Securities class actions against the life science sector continue to rise

life scienceIn 2015, 39 out of the 191 securities class action suits filed were against firms in the life science sector.  Companies in the life science sector tend to get hit with suits because of the variety of allegations that can be thrown at them. Some of these allegations relate to regulatory approvals and the timing and progress of clinical trials, as well as allegations related to product safety, efficiency, and manufacturing.  In 2014, 56% of the suits filed against this sector were related to conducting while the other 44% were related to faulty financial or accounting reporting.

Last year, the science sector had the most securities class actions filed against them compared to any other sector.  In 2016, we’ve seen companies in the life science sector experience had major stock drops with some investigations already pending.  In recent years, we have seen a continuous uptick in suits filed against this sector, and we will be following closely to see if this trend continues throughout this year.

To read more about securities class actions against the life science sectors click here.

About FRT

U.S. CLAIMS  I  GLOBAL GROUP LITIGATION  I  ANTITRUST  I  LITIGATION MONITORING  I  BUYOUTS

Founded in 2008, Financial Recovery Technologies (FRT) is the leading technology-based services firm that helps the investment community identify eligibility, file claims and collect funds made available in securities and other class action settlements. Offering the most comprehensive range of claim filing and monitoring services available, we provide best-in-class eligibility analysis, disbursement auditing and client reporting, and deliver the highest level of accuracy, accountability and transparency available. For more information, go to www.frtservices.com.

This communication and the content found by following any link herein are being provided to you by Financial Recovery Technologies (FRT) for informational purposes only and does not constitute advice. All material presented herein is believed to be reliable but FRT makes no representation or warranty with respect to this communication or such content and expressly disclaims any implied warranty under law. Opinions expressed in this communication may change without prior notice. Firms should always seek legal and financial advice specific to their unique situation and objectives.